CymaBay Therapeutics’ $258.75 Million Follow-On Offering

Pietro Martinoia
Tagged:

Cooley advised CymaBay, and Paul Hastings advised the representatives of the underwriters.CymaBay Therapeutics, Inc. announced its $258.75 million follow-on offering of common stock and pre-funded warrants,…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Pietro Martinoia

…

This content is for Standard 1 Year members only.
Login Join Now